Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors

Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors

US Patent 11008323 · Granted May 18, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-azaindazole derivatives as adenosine receptor antagonists2025
5-azaindazole derivatives as adenosine receptor antagonists2025
5-azaindazole derivatives as adenosine receptor antagonists2025
Substituted heterocyclic compounds as allosteric modulators of group II metabotr2022
Substituted heterocyclic compounds as allosteric modulators of group II metabotr2022
Substituted heterocyclic compounds as allosteric modulators of group II metabotr2022
Chromone oxime derivative and its use as allosteric modulator of metabotropic gl2019
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modul2019
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modul2019
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modul2019
Chromone oxime derivative and its use as allosteric modulator of metabotropic gl2018
Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modul2016